EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review.

[1]  J. Borrás,et al.  EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. , 2013, European journal of cancer.

[2]  K. Havenga,et al.  Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  H. Johansson,et al.  Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial , 2013, The British journal of surgery.

[4]  K. Haustermans,et al.  Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial , 2013 .

[5]  K. Bujko.  Short-course preoperative radiotherapy for low rectal cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Rödel,et al.  Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer , 2013, Radiation oncology.

[7]  J. Lindebjerg,et al.  Clinical Investigation : Gastrointestinal Cancer Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer : A Randomized Trial Comparing Two Radiation Doses , 2022 .

[8]  D. Goldstein,et al.  Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  B. Minsky.  Short-course radiation versus long-course chemoradiation for rectal cancer: making progress. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  T. Conroy,et al.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H. Brenner,et al.  Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study , 2012, International journal of cancer.

[12]  C. Rödel,et al.  Short-course radiation versus long-course chemoradiation for rectal cancer. , 2012, The Journal of the National Comprehensive Cancer Network.

[13]  V. Valentini,et al.  Current perspectives on preoperative integrated treatments for locally advanced rectal cancer: a review of agreement and controversies. , 2012, Oncology.

[14]  L. Collette,et al.  What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? , 2012, European journal of cancer.

[15]  Torsten Hothorn,et al.  Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. , 2012, The Lancet. Oncology.

[16]  D. Tait,et al.  Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B. Glimelius,et al.  Preoperative short‐course radiotherapy with delayed surgery in primary rectal cancer , 2012, The British journal of surgery.

[19]  A. Rosman,et al.  Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis , 2012, Annals of Surgical Oncology.

[20]  B. Minsky.  Progress in the treatment of locally advanced clinically resectable rectal cancer. , 2011, Clinical colorectal cancer.

[21]  M. Cvancarova,et al.  Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study. , 2011, International journal of radiation oncology, biology, physics.

[22]  Vincenzo Valentini,et al.  Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  L. Boni,et al.  Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Hein Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. , 2011, The Lancet. Oncology.

[25]  G. Calais,et al.  Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial. , 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[26]  L. Påhlman,et al.  Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer , 2010, The British journal of surgery.

[27]  A. Melcher,et al.  Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  J. Borrás,et al.  Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  J. Monson,et al.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.

[30]  M. Dietel,et al.  Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society , 2009, BMC Cancer.

[31]  E. Huang.  Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer , 2009 .

[32]  C. Capirci,et al.  Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. , 2008, International journal of radiation oncology, biology, physics.

[33]  L. Påhlman,et al.  Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Phil Quirke,et al.  What is the role for the circumferential margin in the modern treatment of rectal cancer? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  N. Smith,et al.  Preoperative staging of rectal cancer , 2008, Acta oncologica.

[36]  H. Putter,et al.  The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma , 2007, Annals of surgery.

[37]  Philip Quirke,et al.  The future of the TNM staging system in colorectal cancer: time for a debate? , 2007, The Lancet. Oncology.

[38]  Bernard Leduc,et al.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  K. Bujko,et al.  Long‐term results of a randomized trial comparing preoperative short‐course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer , 2006, The British journal of surgery.

[40]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[41]  E. Venkatraman,et al.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[42]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[43]  E. Urso,et al.  Complete Pathologic Response Following Preoperative Chemoradiation Therapy for Middle to Lower Rectal Cancer Is Not a Prognostic Factor for a Better Outcome , 2004, Diseases of the colon and rectum.

[44]  J. Kładny,et al.  Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  J. Fleshman,et al.  A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[46]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[47]  M. Choti,et al.  Rectal cancer. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.